Millennium Management’s Lyra Therapeutics LYRA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-407
| Closed | -$5.63K | – | 4302 |
|
2024
Q2 | $5.63K | Sell |
407
-7,715
| -95% | -$107K | ﹤0.01% | 3888 |
|
2024
Q1 | $2.53M | Buy |
8,122
+1,602
| +25% | +$498K | ﹤0.01% | 2440 |
|
2023
Q4 | $1.71M | Buy |
6,520
+1,253
| +24% | +$328K | ﹤0.01% | 2537 |
|
2023
Q3 | $1.03M | Buy |
+5,267
| New | +$1.03M | ﹤0.01% | 2899 |
|
2023
Q2 | – | Sell |
-1,162
| Closed | -$120K | – | 4530 |
|
2023
Q1 | $120K | Buy |
+1,162
| New | +$120K | ﹤0.01% | 4009 |
|
2022
Q4 | – | Sell |
-378
| Closed | -$95K | – | 5008 |
|
2022
Q3 | $95K | Sell |
378
-1,396
| -79% | -$351K | ﹤0.01% | 4709 |
|
2022
Q2 | $501K | Sell |
1,774
-480
| -21% | -$136K | ﹤0.01% | 3884 |
|
2022
Q1 | $453K | Sell |
2,254
-805
| -26% | -$162K | ﹤0.01% | 4142 |
|
2021
Q4 | $667K | Buy |
3,059
+696
| +29% | +$152K | ﹤0.01% | 3788 |
|
2021
Q3 | $1.08M | Sell |
2,363
-740
| -24% | -$338K | ﹤0.01% | 3566 |
|
2021
Q2 | $1.25M | Buy |
+3,103
| New | +$1.25M | ﹤0.01% | 3553 |
|
2021
Q1 | – | Sell |
-880
| Closed | -$502K | – | 4730 |
|
2020
Q4 | $502K | Buy |
+880
| New | +$502K | ﹤0.01% | 3237 |
|
2020
Q3 | – | Sell |
-998
| Closed | -$566K | – | 3771 |
|
2020
Q2 | $566K | Buy |
+998
| New | +$566K | ﹤0.01% | 2672 |
|